Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;28(3):276-83.
doi: 10.1007/s10637-009-9245-5. Epub 2009 Apr 9.

The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy

Affiliations

The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy

K Dredge et al. Invest New Drugs. 2010 Jun.

Abstract

Heparan sulfate mimetics, which we have called the PG500 series, have been developed to target the inhibition of both angiogenesis and heparanase activity. This series extends the technology underpinning PI-88, a mixture of highly sulfated oligosaccharides which reached Phase III clinical development for hepatocellular carcinoma. Advances in the chemistry of the PG500 series provide numerous advantages over PI-88. These new compounds are fully sulfated, single entity oligosaccharides attached to a lipophilic moiety, which have been optimized for drug development. The rational design of these compounds has led to vast improvements in potency compared to PI-88, based on in vitro angiogenesis assays and in vivo tumor models. Based on these and other data, PG545 has been selected as the lead clinical candidate for oncology and is currently undergoing formal preclinical development as a novel treatment for advanced cancer.

PubMed Disclaimer

References

    1. Cancer Cell. 2009 Mar 3;15(3):232-9 - PubMed
    1. Semin Thromb Hemost. 2007 Jul;33(5):488-95 - PubMed
    1. Clin Chem. 2003 Jan;49(1):32-40 - PubMed
    1. Nat Rev Cancer. 2002 Jul;2(7):521-8 - PubMed
    1. Nat Rev Drug Discov. 2002 Feb;1(2):140-8 - PubMed

MeSH terms

LinkOut - more resources